---
$id: https://graph.org.ai/products/commodity/51182020
$type: Product
source: UNSPSC
code: "51182020"
title: "Bolandiol"
class: "51182000"
classTitle: "Androgens and androgen inhibitors"
family: "51180000"
familyTitle: "Hormones and hormone antagonists"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Bolandiol

**UNSPSC Code**: 51182020
**Class**: [Androgens and androgen inhibitors](Androgens and androgen inhibitors.mdx)
**Family**: [Hormones and hormone antagonists](../Hormones and hormone antagonists.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anabolic steroid with the molecular formula C18H28O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 49SD6G16U5, chemically known as 3.beta.,17.beta.-dihydroxyestr-4-ene but generally known as bolandiol, which bears US NIH Compound Identifier 70691434. European Medicines Agency schedules bolandiol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05866MIG. Most nations schedule bolandiol under HS 29061900 and SITC 51231. As of Q4 2014, BOLANDIOL remains the US FDA Preferred Term for this commodity. SMILES: CCC(=O)OC1CCC2C3CCC4(C(C3CCC2=C1)CCC4OC(=O)CC)C.

